Application-based: 1.0 contact hours
Release Date: 9/15/12
Expiration Date: 9/15/15
APhA members: To receive the member rate when purchasing this activity, enter “APhAEd” in the promotion code field at check out.
This activity will enable practitioners to make recommendations for treatment of sexually transmitted infections (STIs) and counsel patients who have STIs.
This module may be used as an adjunct to the online Ambulatory Care Review Course for those preparing for the Ambulatory Care Board Certification Specialty Examination or as an independent learning activity to increase the knowledge of (STIs).
At the completion of this application –based activity, the participant will be able to:
1. Describe the contribution pharmacists can make in screening, detecting, and managing a sexually transmitted infection (STI), especially in high-risk patients.
2. Identify key self-care concepts that patients must learn so they can decrease their chances of reinfection or spread of infection.
3. Explain how pharmacists’ interview techniques can help guide therapy decision making.
4. Make specific recommendations for optimizing drug therapy.
5. Describe monitoring and a strategy for ensuring drug therapy was efficacious.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists and American Pharmacists Association are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity provides 1 hour (0.1 CEUs) of continuing pharmacy education credit.
Methods and Formats: This online activity consists of audio and slides for one presentation, an attestation statement, and activity evaluation. Participants must view the entire presentation, complete the attestation statement and course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 1 hour.
Target Audience: This activity is intended for pharmacy practitioners who are seeking to update their knowledge and skills commensurate with a board certification examination.
Development: This activity was developed by The American Society of Health-System Pharmacists and the American Pharmacists Association.
Timothy Brown, Pharm.D., BCACP
Northeastern Ohio Colleges of Medicine and Pharmacy
Director of Clinical Pharmacotherapy
Center for Family Medicine
Akron General Medical Center
2012 APhA and ASHP Ambulatory Care Review Advisory Board
Kelly Epplen, Pharm.D., BCACP
Assistant Professor of Clinical Pharmacy Practice
The James L. Winkle College of Pharmacy
University of Cincinnati
Stuart T. Haines, Pharm.D., BCPS, BCACP, BC-ADM
Professor and Vice Chair for Clinical Services
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Clinical Pharmacy Specialist – Primary care
West Palm Beach VA Medical Center
West Palm Beach, FL
Art Schuna, M.S., BS. Pharm.
Clinical Pharmacy Coordinator and Residency Director
William S. Middleton VA Medical Center
University of Wisconsin School of Pharmacy
In accordance with the Accreditation Council for Continuing Medication Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, APhA and ASHP require that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.
In keeping with this requirement, APhA and ASHP ask that all faculty, advisory board members, planning committee members, content development consultants, and staff complete a disclosure form for each program in which they are involved. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.
All of the above listed advisory board members, faculty and APhA and ASHP staff and consultants report no relationships pertinent to this recertification program.
APhA and ASHP identify and resolve conflicts of interest prior to an individual’s participation in development of content for an educational activity.
|Audience||Activity Number||Credit Amount||Accreditation Period|
|PHARMACIST||ACPE #0204-9999-12-992-H01-P||1 Hour||September 05, 2012 - September 05, 2015|